Balaxi [BALAXI] vs Zota Health Care [ZOTA] Detailed Stock Comparison
Balaxi
NSE
Loading...
Zota Health Care
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Balaxi wins in 9 metrics, Zota Health Care wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Balaxi | Zota Health Care | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.02 | -70.12 | Zota Health Care |
| Price-to-Book Ratio | 1.06 | 18.42 | Balaxi |
| Debt-to-Equity Ratio | 9.64 | 0.61 | Zota Health Care |
| PEG Ratio | -0.14 | -28.05 | Zota Health Care |
| EV/EBITDA | 12.49 | -1,106.50 | Zota Health Care |
| Profit Margin (TTM) | -0.99% | -17.04% | Balaxi |
| Operating Margin (TTM) | 21.39% | -10.35% | Balaxi |
| EBITDA Margin (TTM) | 21.39% | N/A | N/A |
| Return on Equity | -1.24% | -24.83% | Balaxi |
| Return on Assets (TTM) | 11.20% | -12.84% | Balaxi |
| Free Cash Flow (TTM) | $-567.67M | $-959.42M | Balaxi |
| Dividend Yield | N/A | 0.07% | N/A |
| 1-Year Return | -54.92% | 137.77% | Zota Health Care |
| Price-to-Sales Ratio (TTM) | 1.02 | 12.83 | Balaxi |
| Enterprise Value | $5.84B | $46.69B | Zota Health Care |
| EV/Revenue Ratio | 2.42 | 15.94 | Balaxi |
| Gross Profit Margin (TTM) | 44.08% | 56.43% | Zota Health Care |
| Revenue per Share (TTM) | $47 | $122 | Zota Health Care |
| Earnings per Share (Diluted) | $3.42 | $-20.73 | Balaxi |
| Beta (Stock Volatility) | 0.59 | 0.44 | Zota Health Care |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Balaxi vs Zota Health Care Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Balaxi | 0.81% | 4.03% | -2.67% | -8.14% | -33.99% | -37.65% |
| Zota Health Care | 0.23% | -4.00% | 16.56% | 44.43% | 72.88% | 76.58% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Balaxi | -54.92% | -62.62% | -76.27% | 1,396.33% | 1,396.33% | 1,396.33% |
| Zota Health Care | 137.77% | 382.52% | 863.38% | 1,448.58% | 1,448.58% | 1,448.58% |
News Based Sentiment: Balaxi vs Zota Health Care
Balaxi
News based Sentiment: NEGATIVE
Balaxi Pharmaceuticals reported revenue growth but experienced a massive drop in net profit, leading to a significant share price decline and a negative AI prediction. These factors combined create a concerning outlook for investors, making this a significant month for the company's investment story.
Zota Health Care
News based Sentiment: MIXED
September presented a mixed bag for Zota Health Care, with impressive revenue growth overshadowed by continued losses and a stock price decline. While the dividend and AGM were positive signals, the underlying profitability issues remain a significant concern for investors, making this a moderately important month for the company's investment story.
Performance & Financial Health Analysis: Balaxi vs Zota Health Care
| Metric | BALAXI | ZOTA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹2.46B | ₹45.32B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 90,326 | 52,991 |
| 90 Day Avg. Volume | 111,771 | 75,102 |
| Last Close | ₹44.89 | ₹1,407.50 |
| 52 Week Range | ₹42.17 - ₹105.38 | ₹535.00 - ₹1,555.00 |
| % from 52W High | -57.40% | -9.49% |
| All-Time High | ₹216.04 (Oct 12, 2020) | ₹1,555.00 (Sep 15, 2025) |
| % from All-Time High | -79.22% | -9.49% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.26% | 0.84% |
| Quarterly Earnings Growth | 0.35% | 0.84% |
| Financial Health | ||
| Profit Margin (TTM) | -0.01% | -0.17% |
| Operating Margin (TTM) | 0.21% | -0.10% |
| Return on Equity (TTM) | -0.01% | -0.25% |
| Debt to Equity (MRQ) | 9.64 | 0.61 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹41.98 | ₹78.12 |
| Cash per Share (MRQ) | ₹11.86 | ₹0.73 |
| Operating Cash Flow (TTM) | ₹48.66M | ₹-1,007,999,000 |
| Levered Free Cash Flow (TTM) | ₹395.72M | ₹-563,984,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.07% |
| Last 12-Month Dividend | ₹0.00 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Balaxi vs Zota Health Care
| Metric | BALAXI | ZOTA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.02 | -70.12 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.14 | -28.05 |
| Price to Sales (TTM) | 1.02 | 12.83 |
| Price to Book (MRQ) | 1.06 | 18.42 |
| Market Capitalization | ||
| Market Capitalization | ₹2.46B | ₹45.32B |
| Enterprise Value | ₹5.84B | ₹46.69B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.42 | 15.94 |
| Enterprise to EBITDA | 12.49 | -1,106.50 |
| Risk & Other Metrics | ||
| Beta | 0.59 | 0.44 |
| Book Value per Share (MRQ) | ₹41.98 | ₹78.12 |
Financial Statements Comparison: Balaxi vs Zota Health Care
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BALAXI | ZOTA |
|---|---|---|
| Revenue/Sales | ₹707.42M | ₹1.04B |
| Cost of Goods Sold | ₹395.60M | ₹451.33M |
| Gross Profit | ₹311.82M | ₹584.50M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹36.86M | ₹-107.17M |
| EBITDA | ₹23.72M | ₹48.28M |
| Pre-Tax Income | ₹9.03M | ₹-130.85M |
| Income Tax | ₹6.13M | ₹6.93M |
| Net Income (Profit) | ₹2.90M | ₹-137.78M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BALAXI | ZOTA |
|---|---|---|
| Cash & Equivalents | ₹394.00M | ₹21.32M |
| Total Current Assets | ₹2.43B | ₹1.84B |
| Total Current Liabilities | ₹545.32M | ₹1.01B |
| Long-Term Debt | ₹230.46M | ₹1.08B |
| Total Shareholders Equity | ₹2.32B | ₹2.27B |
| Retained Earnings | ₹1.63B | ₹-191.89M |
| Property, Plant & Equipment | ₹55.44M | ₹65.25M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BALAXI | ZOTA |
|---|---|---|
| Operating Cash Flow | N/A | ₹-8.57M |
| Capital Expenditures | N/A | ₹-982,011 |
| Free Cash Flow | N/A | ₹41.94M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BALAXI | ZOTA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 90,326 | 52,991 |
| Average Daily Volume (90 Day) | 111,771 | 75,102 |
| Shares Outstanding | 55.21M | 28.64M |
| Float Shares | 51.20M | 12.58M |
| % Held by Insiders | N/A | 0.00% |
| % Held by Institutions | N/A | 0.00% |
Dividend Analysis & Yield Comparison: Balaxi vs Zota Health Care
| Metric | BALAXI | ZOTA |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹1.00 |
| Last 12-Month Dividend Yield | N/A | 0.07% |
| 3-Year Avg Annual Dividend | ₹0.01 | ₹1.00 |
| 3-Year Avg Dividend Yield | 0.03% | 0.16% |
| 3-Year Total Dividends | ₹0.02 | ₹3.00 |
| Ex-Dividend Date | Jul 01, 2022 | Sep 22, 2025 |